# Eric Leip

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/eric-leip/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,238 |
| Field | Chronic Myeloid Leukemia Treatments |
| h-index | 44 |
| i10-index | 62 |
| Last Known Institution | Pfizer (United States) |
| OpenAlex ID | https://openalex.org/A5005182505 |
| Works | 162 |

## Researcher papers

- [Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results](https://scholariq.org/papers/elranatamab-in-relapsed-or-refractory-multiple-myeloma-phase-2-magnetismm-3/)

## Researcher topics

- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Acute Lymphoblastic Leukemia research](https://scholariq.org/topics/acute-lymphoblastic-leukemia-research/)
- [Eosinophilic Disorders and Syndromes](https://scholariq.org/topics/eosinophilic-disorders-and-syndromes/)

## Researcher university

- [Pfizer (United States)](https://scholariq.org/institutions/pfizer-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.